World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
44144
World Ranking
5570
National Ranking
175

Overview

Marco A. Pierotti is affiliated with the University of Bari Aldo Moro in Italy. Their research spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with particular focus on Cancer Research, Molecular Biology, Oncology, Genetics, and Surgery.

The scientist's work explores several key topics, including:

  • Cancer Genomics and Diagnostics
  • Intraperitoneal and Appendiceal Malignancies
  • Pancreatic and Hepatic Oncology Research
  • BRCA gene mutations in cancer
  • Ovarian cancer diagnosis and treatment
  • Hernia repair and management
  • CRISPR and Genetic Engineering

Recent papers authored or co-authored by Marco A. Pierotti include:

  • Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases, 2022, Journal of Molecular Cell Biology
  • Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives, 2021, The Breast
  • BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA, 2024, Molecular Cell
  • NF1 gene inactivation acts as a tumor driver in RET/RAS-negative medullary thyroid carcinomas, 2023, European Journal of Endocrinology
  • Decellularized Normal and Tumor Extracellular Matrix as Scaffold for Cancer Organoid Cultures of Colorectal Peritoneal Metastases, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Marco A. Pierotti frequently collaborates with several researchers, including:

  • Susanna Zanutto
  • Simone P. Minardi
  • Manuela Gariboldi
  • Luca Varinelli
  • Marcello Guagliò

Key venues where the scientist's work has appeared include:

  • Journal of Molecular Cell Biology
  • The Breast
  • Molecular Cell
  • European Journal of Endocrinology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

    Dario Ponti;Aurora Costa;Nadia Zaffaroni;Graziella Pratesi

  • PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

    Michele Grieco;Massimo Santoro;Maria Teresa Berlingieri;Rosa Marina Melillo

  • Lung cancer: intragenic ERBB2 kinase mutations in tumours.

    Philip Stephens;Chris Hunter;Graham Bignell;Sarah Edkins

  • High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

    Lisa Licitra;Federica Perrone;Paolo Bossi;Simona Suardi

  • The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

    Gabriella Sozzi;Maria Luisa Veronese;Massimo Negrini;Raffaele Baffa

  • Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

    Gabriella Sozzi;Davide Conte;MariaElena Leon;Rosalia Cirincione

  • Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer

    Helen Davies;Chris Hunter;Raffaella Smith;Philip Stephens

  • Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.

    Gabriella Sozzi;Davide Conte;Luigi Mariani;Salvatore Lo Vullo

  • Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

    Giuseppe Bunone;Paolo Vigneri;Luigi Mariani;Simona Butó

  • A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

    A. Fusco;M. Grieco;M. Santoro;M. T. Berlingieri

  • Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient

    E Santos;D Martin-Zanca;EP Reddy;MA Pierotti

  • Association between Cisplatin Resistance and Mutation of p53 Gene and Reduced Bax Expression in Ovarian Carcinoma Cell Systems

    Paola Perego;Monica Giarola;Sabina C. Righetti;Rosanna Supino

  • BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations: Risk Factor Analysis and Implications for Genetic Testing

    Donna Shattuck-Eidens;Arnold Oliphant;Melody McClure;Celeste McBride

  • Replacement of Fhit in cancer cells suppresses tumorigenicity

    Zurab Siprashvili;Gabriella Sozzi;Larry D. Barnes;Peter McCue

  • Molecular characterization of RET/PTC3; A novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma

    Massimo Santoro;Nina A. Dathan;Maria T. Berlingieri;Italia Bongarzone

  • Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

    Sherene Loi;Benjamin Haibe-Kains;Christine Desmedt;Pratyaksha Wirapati

  • PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

    F. Perrone;A. Lampis;M. Orsenigo;M. Di Bartolomeo

  • Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

    M Santoro;F Carlomagno;I D Hay;M A Herrmann

  • Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

    R Donghi;A Longoni;S Pilotti;P Michieli

  • Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

    Francesco Pezzella;Ugo Pastorino;Elda Tagliabue;Salvatore Andreola

Frequent Co-Authors

Silvana Pilotti
Silvana Pilotti University of Milan
Gabriella Sozzi
Gabriella Sozzi University of Milan
Paolo Radice
Paolo Radice Fondazione IRCCS Istituto Nazionale dei Tumori
Maria Grazia Daidone
Maria Grazia Daidone University of Milan
Alessandro Gronchi
Alessandro Gronchi University of Milan
Giorgio Parmiani
Giorgio Parmiani University of Siena
Ugo Pastorino
Ugo Pastorino University of Milan
Sabrina Pricl
Sabrina Pricl University of Trieste
Domenico Delia
Domenico Delia University of Milan
Barbara Pasini
Barbara Pasini University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the broader healthcare field or seeking flexible alternatives to traditional medical study, there are several online pathways worth exploring. Careers such as nursing, medical billing, and healthcare administration offer strong job prospects and can often be pursued via online programs.

Many students look for direct admit nursing programs that streamline entry into the nursing profession. For those who wish to avoid extensive entrance testing, there are also nursing schools that don't require teas or hesi exams, making the process less stressful.

If you’re drawn to the administrative or technical side of healthcare, consider the best medical billing and coding schools online. These programs train you for vital behind-the-scenes roles and often provide the flexibility and affordability of distance learning.

Additionally, pursuing an online healthcare administration degree can prepare you for leadership roles in hospitals or clinics. Each of these options opens diverse career doors and can complement or offer an alternative to a traditional medical degree.

Best Scientists Citing Marco A. Pierotti

Trending Scientists

Recently Published Articles